Fate Therapeutics Inc (FATE) — SC 13G Filings
All SC 13G filings from Fate Therapeutics Inc. Browse 2 Passive Stake Filing reports with AI-powered summaries and risk analysis.
SC 13G Filings (2)
-
Boxer Capital Discloses 10.0% Stake in Fate Therapeutics
— Feb 12, 2024 Risk: low
Boxer Capital, LLC, a Delaware-based investment firm, has disclosed a significant stake in Fate Therapeutics, Inc. (FATE), a biotechnology company. As of Januar -
Point72 Discloses 4.73M Share Stake in Fate Therapeutics
— Jan 25, 2024
Point72 Asset Management, L.P. reported on January 24, 2024, that it beneficially owns 4,730,700 shares of Fate Therapeutics, Inc. common stock, representing a
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX